Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
Effect of novel CAAX peptidomimetic farnesyltransferase inhibitor on angiogenesis in vitro and in vivoW Z Gu, S K Tahir, Y C Wang, et al.Polish Journal of Veterinary Sciences|December 30, 2024
Neuro-protective and redox potential of troxerutin against cypermethrin-induced neurotoxicity and oxidative stress in miceS Shehzad, Z Farooq, S K Tahir, et al.Cancer Research|March 14, 2001
Identification and characterization of A-105972, an antineoplastic agentJ R Wu-Wong, J D Alder, L Alder, et al.Neoplasia (New York, N.Y.)|August 10, 2000
Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growthJ Chen, W Wu, S K Tahir, et al.Cancer Research|July 17, 2001
A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitorsS K Tahir, E K Han, B Credo, et al.European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
Inhibition of farnesyltransferase with A-176120, a novel and potent farnesyl pyrophosphate analogueS K Tahir, W Z Gu, H C Zhang, et al.Anticancer Research|April 13, 2001
Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agentsY Luo, S K Rockow-Magnone, M K Joseph, et al.Cell Death and Differentiation|January 6, 2007
Bcl-2 family proteins are essential for platelet survivalH Zhang, P M Nimmer, S K Tahir, et al.Cell Death & Disease|January 16, 2015
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)J D Leverson, H Zhang, J Chen, et al.Pageof 2